Healthy products

It is fundamental that the products are safe and meet consumers’ expectations. Quality is a key factor, from ensuring that research on product benefits is reliable to guaranteeing that the product retains its high quality when it reaches consumers.

One of BioGaia’s key strengths is the large number of well-executed independent clinical studies on the products. BioGaia’s probiotic strain, L. reuteri DSM 17938, is the world’s most scientifically-studied probiotic bacterium that remains patented.

Providing transparent information on research strengthens stakeholder confidence and ensures that consumers receive safe products with the benefits they require.

BioGaia applies the International Scientific Association for Probiotics and Prebiotics (ISAPP) criteria for probiotic products, including how these should be labelled.

BioGaia checks every single batch that is produced against the applicable requirements. BioGaia also monitors contract manufacturers’ compliance with the applicable quality requirements through documented reviews and periodic audits. BioGaia has never needed to recall products already distributed to consumers. The company’s quality work also aims to identify potential improvements in documentation and production processes. For example, during 2020 the Protectis portfolio was declared allergen-free and work is ongoing so that this can apply to the remaining product families.

A new life-cycle assessment was carried out during 2020, covering both packaging and the ingredients used in the products. This will enable BioGaia to better understand the company’s environmental impact. A tool has also been developed that allows these results to be integrated into the product development process.

Palm oil is one example of an ingredient that has a significant impact on both people and the environment. At the end of 2020, some 70% (35%) of product formulations were available in variants without palm oil. BioGaia buys credits for the palm oil which is used from RSPO-certified independent smallholders in accordance with RSPO’s Book and Claim system. The aim is to stop selling any products containing palm oil by 2025.

Developing new sustainable packaging remains a priority where the biggest challenge is to find a solution that does not compromise the quality of the bacteria which are extremely sensitive to water and oxygen. A project team has been created to intensify development work during 2021. An increasing use of monomaterial in packaging and consumer communication to increase recyclability rates are examples of small changes introduced during the year to reduce impact.

Strain or strain combination
Published articles
L. reuteri DSM 17938
L. reuteri DSM 17938 & L. reuteri ATCC PTA 5289
L. reuteri DSM 17938 & L. reuteri ATCC PTA 6475
L. reuteri ATCC PTA 6475